Increased levels of atherosclerosis markers in salt-sensitive hypertension

American Journal of Hypertension

Volumn 19, Issue 1, 2006, Pages 87-93

  Larrousse, Maria ^a   Bragulat, Ernesto ^a   Segarra, Marta ^a   Sierra, Cristina ^a   Coca, Antonio ^a   De La Sierra, Alejandro ^a  

^a HOSPITAL CLÍNIC   (Spain)

Author keywords

Atherosclerosis; Cell adhesion molecules; Dietary sodium; Endothelium; Extracellular matrix; Inflammation; Sodium dependent hypertension

Indexed keywords

C REACTIVE PROTEIN; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; GELATINASE A; GELATINASE B; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 6; INTERSTITIAL COLLAGENASE; MONOCYTE CHEMOTACTIC PROTEIN 1; PADGEM PROTEIN; TISSUE INHIBITOR OF METALLOPROTEINASE 1; VASCULAR CELL ADHESION MOLECULE 1;

ADULT; ARTICLE; ATHEROSCLEROSIS; BLOOD LEVEL; BLOOD PRESSURE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FOREARM BLOOD FLOW; HUMAN; HYPERTENSION; MALE; PRIORITY JOURNAL; SALT INTAKE; VASODILATATION;

ADULT; ATHEROSCLEROSIS; BIOLOGICAL MARKERS; BLOOD PRESSURE; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; CELL ADHESION MOLECULES; CHEMOKINE CCL2; COLLAGENASES; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; HYPERTENSION; INTERLEUKIN-6; MALE; MIDDLE AGED; RISK FACTORS; SODIUM, DIETARY; TISSUE INHIBITOR OF METALLOPROTEINASE-1;

EID: 32344445991     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjhyper.2005.06.019     Document Type: Article

References (32)

1. M. Muntzel, T. Drüeke A comprehensive review of the salt and blood pressure relationship Am J Hypertens 5 1992 1S 42S
2. M.H. Weinberger Salt sensitivity of blood pressure in humans Hypertension 27 1996 481 490
3. T. Nakagawa, D.H. Kang, R. Ohashi, S. Suga, J. Herrera-Acosta, B. Rodriguez-Iturbe, R.J. Johnson Tubulointerstitial disease role of ischemia and microvascular disease Curr Opin Nephrol Hypertens 12 2003 233 241
4. V. Giner, E. Poch, E. Bragulat, J. Oriola, D. González, A. Coca, A. de la Sierra Renin-angiotensin system genetic polymorphisms and salt sensitivity in essential hypertension Hypertension 35 2000 512 517
5. A. De la Sierra, M.M. Lluch, A. Coca, M.T. Aguilera, V. Giner, E. Bragulat, A. Urbano-Márquez Fluid, ionic and hormonal changes induced by high salt intake in salt-sensitive and salt-resistant hypertensive patients Clin Sci 91 1996 155 161
6. M.M. Lluch, A. de la Sierra, E. Poch, A. Coca, M.T. Aguilera, M. Compte, A. Urbano-Márquez Erythrocyte sodium transport, intraplatelet pH, and calcium concentration in salt-sensitive hypertension Hypertension 27 1996 919 925
7. A. Morimoto, T. Uzu, T. Fujii, M. Nishimura, S. Kuroda, S. Nakamura, T. Inenaga, G. Kimura Sodium sensitivity and cardiovascular events in patients with essential hypertension Lancet 350 1997 1734 1737
8. M.H. Weinberger, N.S. Fineberg, S.E. Fineberg, M. Weinberger Salt sensitivity, pulse pressure, and death in normal and hypertensive humans Hypertension 37 2001 429 432
9. A. De la Sierra, M.M. Lluch, A. Coca, M.T. Aguilera, M. Sánchez, C. Sierra, A. Urbano-Márquez Assessment of salt-sensitivity in essential hypertension by twenty-four hour ambulatory blood pressure monitoring Am J Hypertens 8 1995 970 977
10. A. De la Sierra, M.M. Lluch, J.C. Paré, A. Coca, M.T. Aguilera, M. Azqueta, A. Urbano-Márquez Increased left ventricular mass in salt-sensitive hypertensive patients J Hum Hypertens 10 1996 795 799
11. A. Bihorac, H. Tezcan, C. Ozener, A. Oktay, E. Akoglu Association between salt sensitivity and target organ damage in essential hypertension Am J Hypertens 13 2000 864 872
12. E. Bragulat, A. de la Sierra, M.T. Antonio, A. Coca Endothelial dysfunction in salt-sensitive essential hypertension Hypertension 37 2001 444 448
13. R. Ross Atherosclerosis. An inflammatory disease N Engl J Med 340 1999 115 126
14. F. Perticone, R. Ceravolo, A. Pujia, G. Ventura, S. Iacopino, A. Scozzafava, A. Ferraro, M. Chello, P. Mastroroberto, P. Verdecchia, G. Schillaci Prognostic significance of endothelial dysfunction in hypertensive patients Circulation 104 2001 191 196
15. C.A. DeSouza, D.R. Dengel, R.F. Macko, K. Cox, D.R. Seals Elevated levels of circulating cell adhesion molecules in uncomplicated essential hypertension Am J Hypertens 10 1997 1335 1341
16. R.A. Preston, M. Ledford, B.J. Materson, N.M. Baltodano, A. Memon, A. Alonso Effects of severe, uncontrolled hypertension on endothelial activation soluble vascular cell adhesion molecule-1, soluble intercellular adhesion molecule-1 and von Willebrand factor J Hypertens 20 2002 871 877
17. C. Laviades, N. Varo, J. Fernández, G. Mayor, M.J. Gil, I. Monreal, J. Díez Abnormalities of the extracellular degradation of collagen type I in essential hypertension Circulation 98 1998 535 540
18. A. Zervoudaki, E. Economou, C. Stefanadis, C. Pitsavos, K. Tsioufis, C. Aggeli, K. Vasiliadou, M. Toutouza, P. Toutouzas Plasma levels of active extracellular matrix metalloproteinases 2 and 9 in patients with essential hypertension before and after antihypertensive treatment J Hum Hypertens 17 2003 119 124
19. J.B. Meigs, F.B. Hu, N. Rifai, J.E. Manson Biomarkers of endothelial dysfunction and risk of type 2 diabetes mellitus JAMA 291 2004 1978 1986
20. Y.T. Kuroda, K. Komamura, R. Tatsumi, K. Mori, K. Yoneda, Y. Katayama, S. Shigemoto, K. Miyatake, T. Hanafusa Vascular cell adhesion molecule-1 as a biochemical marker of left ventricular mass in the patients with hypertension Am J Hypertens 14 2001 868 872
21. P.M. Timms, A. Wright, P. Maxwell, S. Campbell, A.B. Dawnay, V. Srikanthan Plasma tissue inhibitor of metalloproteinase-1 levels are elevated in essential hypertension and related to left ventricular hypertrophy Am J Hypertens 15 2002 269 272
22. S. Blankenberg, H.J. Rupprecht, C. Bickel, D. Peetz, G. Hafner, L. Tiret, J. Meyer Circulating cell adhesion molecules and death in patients with coronary artery disease Circulation 104 2001 1336 1342
23. J.A. De Lemos, D.A. Morrow, M.S. Sabatine, S.A. Murphy, C.M. Gibson, E.M. Antman, C.H. McCabe, C.P. Cannon, E. Braunwald Association between plasma levels of monocyte chemoattractant protein-1 and long term clinical outcomes in patients with acute coronary syndromes Circulation 107 2003 690 695
24. S. Blankenberg, H.J. Rupprecht, O. Poirier, C. Bickel, M. Smieja, G. Hafner, J. Meyer, F. Cambien, L. Tiret Plasma concentrations and genetic variation of matrix metalloproteinase 9 and prognosis of patients with cardiovascular disease Circulation 107 2003 1579 1585
25. C. Ferri, C. Bellini, G. Desideri, E. Giuliani, L. De Siati, S. Cicogna, A. Santucci Clustering of endothelial markers of vascular damage in human salt-sensitive hypertension. Influence of dietary sodium load and depletion Hypertension 32 1998 862 868
26. E. Bragulat, M. Larrousse, A. Coca, A. de la Sierra Effect of long-term irbesartan treatment on endothelium-dependent vasodilation in essential hypertensive patients Br J Biomed Sci 60 2003 191 196
27. D. Denton, R. Weisinger, N.I. Mundy, E.J. Wickings, A. Dixson, P. Moisson, A.M. Pingard, R. Shade, D. Carey, R. Ardaillaou, F. Paillard, J. Chapman, J. Thillet, J.B. Michel The effect of increased salt intake on blood pressure of chimpanzees Nat Med 1 1995 1009 1016
28. A.D. Blann, S.K. Nadar, G.Y.H. Lip The adhesion molecule P-selectin and cardiovascular disease Eur Heart J 24 2003 2166 2179
29. V. Roldan, F. Marin, G.Y.H. Lip, A.D. Blann Soluble E-selectin in cardiovascular disease and its risk factors Thromb Haemost 90 2003 1007 1020
30. P.M. Ridker, J.E. Buring, N. Rifai Soluble P-selectin and the risk of future cardiovascular events Circulation 103 2001 491 495
31. K. Egashira Molecular mechanisms mediating inflammation in vascular disease. Special reference to monocyte chemoattractant protein-1 Hypertension 41 2003 834 841
32. Z.S. Galis, J.J. Khatri Matrix metalloproteinases in vascular remodelling and atherogenesis. The good, the bad, and the ugly Circ Res 90 2002 251 262